TipRanks
Go Ultimate55% OFF

Paul T. Quinlan Insider Profile

4 Followers

Paul T. Quinlan, GC at Oruka Therapeutics, holds 30.00K shares in Oruka Therapeutics (Ticker: ORKA), holds 0.00 shares in CymaBay Therapeutics (Ticker: CBAY), holds 76.75K shares in TerraVia Holdings Inc (Ticker: TVIAQ).

Paul T. Quinlan's Trading History

ORKA
Oruka Therapeutics
Oct 20, 2026GCUninformative Buy70.20K$2.91M
CBAY
CymaBay Therapeutics
Mar 22, 2024―Uninformative Sell―$0.00
TVIAQ
TerraVia Holdings Inc
Mar 13, 2017―Uninformative Sell20.00K$1.15K

You May Also Like

Paul T. Quinlan insider profile FAQ

What is the percentage of profitable transactions made by Paul T. Quinlan?
The percentage of profitable transactions made by Paul T. Quinlan is 0%.
What is the average return per transaction made by Paul T. Quinlan?
The average return per transaction made by Paul T. Quinlan is -22.80%.
What stocks does Paul T. Quinlan hold?
Paul T. Quinlan holds: ORKA, TVIAQ, CBAY stocks.
What was Paul T. Quinlan’s latest transaction?
Paul T. Quinlan’s latest transaction was an Uninformative Buy of $70.20K.
What was Paul T. Quinlan's most profitable transaction?
Paul T. Quinlan’s most profitable transaction was an Informative Sell of ORKA stock on September 15, 2026. The return on the trade was -5.00%.
What is Paul T. Quinlan's role in Oruka Therapeutics?
Paul T. Quinlan's role in Oruka Therapeutics is GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.